ChemAbout

ChemAbout is a B2B platform where chemical buyers and suppliers discover each other.

Post a purchase requestList your products (for suppliers)
© 2026 ChemAbout
Compound Index|Demand Board|Insights|Exhibitions|Compliance|Help Center|Privacy Policy|Terms of Service|[email protected]
Home/Compounds/API/Cyclosporin d
C63H113N11O12
1216.6 g/mol
APIDanger

Cyclosporin D

CAS63775-96-2EC806-434-4
Category
API
Compound Class
Peptide
Primary Use
Pharmaceutical Raw Material

Cyclosporin D is a macrolide compound from the cyclosporin group, isolated from fungi and structurally related to the immunosuppressant agent cyclosporin A. It is primarily used as an active pharmaceutical ingredient in pharmaceutical manufacturing and research.

pharmaceutical raw material for immunosuppressant researchreference standard in analytical testing

Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.

Sourcing Cyclosporin D?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→

Related Compounds

StrongStructure SimilarSimilarity 0.97

Cyclosporin b

CAS63775-95-1

pharmaceutical raw material

StrongStructure SimilarSimilarity 0.96

Cyclosporin c

CAS59787-61-0

pharmaceutical raw material

StrongStructure SimilarSimilarity 0.89

Cyclosporine

CAS79217-60-0

pharmaceutical raw material

StrongStructure SimilarSimilarity 0.89

Cyclosporine

CAS59865-13-3

pharmaceutical raw material

ApplicationSame Use

Sirolimus

CAS53123-88-9

pharmaceutical raw material

ReferenceSame Category

L-carbocysteine

CAS638-23-3

pharmaceutical raw material

ReferenceSame Category

Desonide

CAS638-94-8

pharmaceutical raw material

ReferenceSame Category

Nonathymulin

CAS63958-90-7

pharmaceutical raw material

Related Reading

Therapeutic Peptides in 2026: This Year's Breakthroughs

2026 has been a concentrated year for peptide therapeutics. Efficacy reached a new high in late-stage trials, the obesity field moved beyond the incretins to amylin, the oral route reached weight management, and peptide-guided radioligand therapy kept advancing — each point tied to a specific 2025–2026 result.

Read more

Safety Reference

Harmful
Harmful
Health Hazard
Health Hazard
Danger
H302Harmful if swallowed
H350May cause cancer
H351Suspected of causing cancer
H362May cause harm to breast-fed children
Identifiers
IUPAC Name

(3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-33-[(E,1R,2R)-1-hydroxy-2-methylhex-4-enyl]-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21,30-tri(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone

InChIKey

ZNVBEWJRWHNZMK-SYOLRUPNSA-N

SMILES

C/C=C/C[C@@H](C)[C@H]([C@H]1C(=O)N[C@H](C(=O)N(CC(=O)N([C@H](C(=O)N[C@H](C(=O)N([C@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N1C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C)C(C)C)O

Synonyms (13)
  • 7-L-valine-cyclosporin A
  • CYCLOSPORINE D
  • Ciclosporin Impurity G
  • Cyclosporin A, 7-L-valine-
  • Cyclosporin D
  • [Val7]ciclosporin A

Sourcing Cyclosporin D?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→